Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Association between plasma ceramides and hosphatidylcholines and hippocampal brain volume in late onset Alzheimer's disease

Kim, M., Nevado-Holgado, A., Whiley, L.ORCID: 0000-0002-9088-4799, Snowden, S.G., Soininen, H., Kloszewska, I., Mecocci, P., Tsolaki, M., Vellas, B., Thambisetty, M., Dobson, R.J.B., Powell, J.F., Lupton, M.K., Simmons, A., Velayudhan, L., Lovestone, S., Proitsi, P., Legido-Quigley, C., Mielke, M. and Martinez, P. (2017) Association between plasma ceramides and hosphatidylcholines and hippocampal brain volume in late onset Alzheimer's disease. Journal of Alzheimer's Disease, 60 (3). pp. 809-817.

[img]
Preview
PDF - Published Version
Download (418kB) | Preview
Free to read: https://doi.org/10.3233/JAD-160645
*No subscription required

Abstract

Lipids such as ceramides and phosphatidylcholines (PC) have been found altered in the plasma of Alzheimer’s disease (AD) patients in a number of discovery studies. For this reason, the levels of 6 ceramides and 3 PCs, with different fatty acid length and saturation levels, were measured in the plasma from 412 participants (AD n = 205, Control n = 207) using mass spectrometry coupled with ultra-performance liquid chromatography. After this, associations with AD status, brain atrophy, and age-related effects were studied. In the plasma of AD participants, cross-sectional analysis revealed elevated levels of three ceramides (Cer16:0 p < 0.01, Cer18:0 p < 0.01, Cer24:1 p < 0.05). In addition, two PCs in AD plasma (PC36:5 p < 0.05, PC38:6 p < 0.05) were found to be depleted compared to the control group, with PC36:5 also associating with hippocampal atrophy (p < 0.01). Age-specific analysis further revealed that levels of Cer16:0, Cer18:0, and Cer20:0 were associated with hippocampal atrophy only in younger participants (age < 75, p < 0.05), while all 3 PCs did so in the older participants (age > 75, p < 0.05). PC36:5 was associated with AD status in the younger group (p < 0.01), while PC38:6 and 40:6 did so in the older group (p < 0.05). In this study, elevated ceramides and depleted PCs were found in the plasma from 205 AD volunteers. Our findings also suggest that dysregulation in PC and ceramide metabolism could be occurring in different stages of AD progression.

Item Type: Journal Article
Publisher: IOS Press
Copyright: © 2017 – IOS Press and the authors
URI: http://researchrepository.murdoch.edu.au/id/eprint/54717
Item Control Page Item Control Page

Downloads

Downloads per month over past year